Upper vs Lower Extremity BP in Spinal Cesarean Using ClearSight
Ohio State University · NCT07685730
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · Women only
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 327
- US sites recruiting
- 1
- Study start
- February 6, 2025
- Record last updated
- July 6, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This is a single-center, prospective observational study in patients undergoing cesarean delivery under spinal or combined spinal-epidural anesthesia. It compares whether continuous noninvasive hemodynamic measurements from the lower extremity (toe) better predict neonatal outcomes than upper extremity (arm/finger) measurements during spinal-induced hypotension.
Participants receive standard spinal anesthesia and routine blood pressure management, with additional monitoring using the ClearSight™ system at both upper and lower extremities from before spinal anesthesia through delivery.
The primary outcome is a composite of neonatal outcomes (APGAR scores, need for respiratory support, cord gases, and NICU admission). Secondary outcomes include maternal side effects and comfort.
Overall, the study evaluates whether lower-extremity hemodynamic monitoring improves detection of clinically relevant hypotension and prediction of neonatal outcomes compared to traditional arm measurements.
Being studied: ClearSight
Conditions: Anesthesia; Pregnancy Related; Blockades Neuromuscular
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Age ≥ 18 years old
- Singleton pregnancy
- Gestational age ≥ 37 weeks
- Women undergoing CD under SAB or Combined Spinal-Epidural (CSE) electively.
- Ability to consent in English and in Spanish language
Exclusion Criteria
- CD under or converted to general anesthesia
- CD under epidural anesthesia or converted to epidural anesthesia
- Diabetes Mellitus (DM)/Gestational Diabetes Mellitus (GDM)
- Evidence of unstable cardiac disease other than HDP (including chronic hypertension, gestational hypertension, preeclampsia-eclampsia, and chronic hypertension with superimposed preeclampsia) judged by the investigator to have any impact on BP will make the subject unsuitable for participation in the study
- Documented fetal anomaly/ congenital malformations and genetic syndromes
- Intrauterine growth retardation
- Unable to consent in English/Spanish.
- Prisoners
Recruiting US locations
The Ohio State University
Columbus, OH 43210
Site contact: Alberto Uribe, MD · 6142933559 · alberto.uribe@osumc.edu
Study contacts (from the official record)
- Ling-Qun Hu, MD · 6142936302 · LingQun.Hu@osumc.edu
- Alberto Uribe, MD · 6142933559 · Alberto.uribe@osumc.edu
Similar studies in Ohio
All pregnancy studies in Ohio →- RecruitingHealthy volunteersPhase 3
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
Pfizer
- Location
- Cincinnati, OH + 76 other US sites
- Eligibility basics
- Ages 0 mo+
- RecruitingHealthy volunteersPhase 3
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
Pfizer
- Location
- Cincinnati, OH + 111 other US sites
- Eligibility basics
- Ages 0 mo–49
- RecruitingPhase 2
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
Seaport Therapeutics
- Location
- Independence, OH + 26 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 3
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
Ascendis Pharma A/S
- Location
- Cincinnati, OH + 21 other US sites
- Eligibility basics
- Ages 2–17